Correction: Diabetes management.
Where this comes from
- Record sourced from PubMed, PMID 31710592.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Information was omitted from Table 1 on page 596 of the article, Makin V, Lansang MC. Diabetes management: beyond hemoglobin A<sub>1c</sub> (Cleve Clin J Med 2019; 86[9]:595-600, doi:10.3949/ccjm.86a.18031). The sodium-glucose cotransporter 2 (SGLT2) inhibitors pose a low risk of hypoglyemia, and that should have been noted in the table. The corrected table appears online.